Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
17.30
+0.61 (3.65%)
Nov 2, 2026, 4:00 PM EST - Market closed
Dyne Therapeutics Market Cap
Dyne Therapeutics has a market cap or net worth of $3.23 billion as of November 2, 2026. It is the 4,944th most valuable company in the world and the 1,484th biggest in the United States. Its market cap has increased by 0.57% in one year.
Market Cap
3.23B
Enterprise Value
2.57B
1-Year Change
0.57%
Global Rank
Country Rank
#1,484 United States
Category
ChartMarket Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $3.23B, an increase of 308.49%. That is a compound annual growth rate of 25.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 3.23B | 0.31% |
| Dec 31, 2025 | 3.22B | 34.33% |
| Dec 31, 2024 | 2.40B | 193.72% |
| Dec 29, 2023 | 816.30M | 35.12% |
| Dec 30, 2022 | 604.12M | -0.31% |
| Dec 31, 2021 | 606.03M | -36.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Parabilis Medicines | 3.50B |
| Viking Therapeutics | 3.48B |
| Celcuity | 3.38B |
| Tarsus Pharmaceuticals | 3.28B |
| Enliven Therapeutics | 3.24B |
| IDEAYA Biosciences | 3.08B |
| Denali Therapeutics | 3.03B |
| Nurix Therapeutics | 2.93B |